AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AVECHO BIOTECHNOLOGY LTD

0.021

+0.00210.53%

Volume:6.55M

Turnover:127.39K

Market Cap:81.14M

PE:-15.00

High:0.021

Open:0.020

Low:0.019

Close:0.019

52wk High:0.027

52wk Low:0.005

Shares:3.86B

Float Shares:1.90B

Volume Ratio:3.04

T/O Rate:0.35%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.001

EPS(LYR):-0.001

ROE:-182.91%

ROA:-40.85%

PB:52.02

PE(LYR):-15.00

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Avecho Biotechnology Says Japanese Patent Granted for CBD Capsule

Avecho Biotechnology Ltd-Japanese Patent Granted for Cbd Capsule

THOMSON REUTERS

Avecho to Continue With Full Enrollment in Insomnia Trial After Positive Data Monitoring Board Recommendation; Shares Hit 5.5-Year High

MT Newswires Live

BRIEF-Avecho Biotechnology Seeks Trading Halt

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/AVE.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AVE.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVE.AU\",,,,,undefined,":{"symbol":"AVE.AU","market":"AU","secType":"STK","nameCN":"AVECHO BIOTECHNOLOGY LTD","latestPrice":0.021,"timestamp":1787292720000,"preClose":0.019,"halted":0,"volume":6553748,"delay":0,"changeRate":0.10526315789473693,"nameEN":"AVECHO BIOTECHNOLOGY LTD","floatShares":1896395886,"shares":3863725873,"eps":-0.0014,"marketStatus":"Market Closed","change":0.002,"latestTime":"08-21 16:12:00 AEST","open":0.02,"high":0.021,"low":0.019,"amount":127394,"amplitude":0.105263,"askPrice":0.021,"askSize":562480,"bidPrice":0.02,"bidSize":2280734,"shortable":3,"etf":0,"ttmEps":-0.0014,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787529600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.019,"openAndCloseTimeList":[[1787270400000,1787292000000]],"volumeRatio":3.0364978465803802,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"AVE.AU","preClose":0.019,"auctionPrice":0.022,"auctionVolume":682479,"auction":3,"marketStatus":"盘后竞价","timestamp":1787292331290}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"AVE.AU\",,,,,undefined,":{"symbol":"AVE.AU","floatShares":1896395886,"roa":"-40.85%","roe":"-182.91%","lyrEps":-0.0014,"volumeRatio":3.0364978465803802,"shares":3863725873,"dividePrice":0,"high":0.021,"amplitude":0.105263,"preClose":0.019,"low":0.019,"week52Low":0.005,"pbRate":"52.02","psRate":"65.55","week52High":0.027,"institutionHeld":0,"latestPrice":0.021,"committee":0.604335,"eps":-0.0014,"divideRate":0,"volume":6553748,"delay":0,"ttmEps":-0.0014,"open":0.02,"prevYearClose":0.009,"prevWeekClose":0.02,"prevMonthClose":0.019,"prevQuarterClose":0.024,"fiveDayClose":0.02,"twentyDayClose":0.021,"sixtyDayClose":0.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AVE.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AVE.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AVE.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2656346629","title":"Avecho Biotechnology Says Japanese Patent Granted for CBD Capsule","url":"https://stock-news.laohu8.com/highlight/detail?id=2656346629","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656346629?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:49","pubTimestamp":1785714569,"startTime":"0","endTime":"0","summary":"BRIEF-Avecho Biotechnology Says Japanese Patent Granted For CBD CapsuleAug 3 (Reuters)-Avecho Biotechnology LtdAVE.AX:JAPANESE PATENT GRANTED FOR CBD CAPSULEFurther company coverage:AVE.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260802:nTUE7DBFNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVE.AU","BK7096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656648346","title":"Avecho Biotechnology Ltd-Japanese Patent Granted for Cbd Capsule","url":"https://stock-news.laohu8.com/highlight/detail?id=2656648346","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656648346?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:48","pubTimestamp":1785714504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260802:nTUE7DBFNR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","AVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645863328","title":"Avecho to Continue With Full Enrollment in Insomnia Trial After Positive Data Monitoring Board Recommendation; Shares Hit 5.5-Year High","url":"https://stock-news.laohu8.com/highlight/detail?id=2645863328","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645863328?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:20","pubTimestamp":1782264025,"startTime":"0","endTime":"0","summary":"Avecho Biotechnology  said an independent data monitoring board recommended that the company's phase 3 clinical trial evaluating TPM-enhanced cannabidiol capsule for insomnia continue to the full planned enrolment of 519 participants, according to a Wednesday filing with the Australian bourse.The data monitoring board issued the recommendation following an interim analysis that showed no serious adverse events across 244 initial participants.\"The interim analysis represents a major value-inflection point for the program, reducing clinical development risk and providing a defined pathway toward completion of the pivotal study,\" the company said.Avecho added that it has already identified additional clinical sites to speed up the recruitment of the second patient cohort.The company's shares gained 33% in recent Wednesday activity and earlier hit their highest since December 2020.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","AVE.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645019464","title":"BRIEF-Avecho Biotechnology Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2645019464","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645019464?lang=en_us&edition=fundamental","pubTime":"2026-06-22 06:31","pubTimestamp":1782081110,"startTime":"0","endTime":"0","summary":"BRIEF-Avecho Biotechnology Seeks Trading Halt June 22 (Reuters) - Avecho Biotechnology Ltd AVE.AX:SEEKS TRADING HALT PENDING OUTCOME OF PHASE III CBD TPM CAPSULE TRIAL ANALYSISFurther company coverage: AVE.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260621:nFWN42S063:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","AVE.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":11,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/AVE.AU\",params:#limit:6,delay:true,,,undefined,":[]}}